CAPSOVISION INC (CV) Stock Fundamental Analysis

NASDAQ:CV • US1409351079

4.95 USD
-0.43 (-7.99%)
At close: Feb 24, 2026
4.95 USD
0 (0%)
After Hours: 2/24/2026, 8:19:07 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

CV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While CV has a great health rating, there are worries on its profitability. While showing a medium growth rate, CV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CV had negative earnings in the past year.
CV Yearly Net Income VS EBIT VS OCF VS FCFCV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • CV has a worse Return On Assets (-147.38%) than 85.95% of its industry peers.
  • The Return On Equity of CV (-185.01%) is worse than 71.89% of its industry peers.
Industry RankSector Rank
ROA -147.38%
ROE -185.01%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CV Yearly ROA, ROE, ROICCV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 -50 -100

1.3 Margins

  • CV's Gross Margin of 54.21% is in line compared to the rest of the industry. CV outperforms 51.35% of its industry peers.
  • CV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CV Yearly Profit, Operating, Gross MarginsCV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • CV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CV has about the same amout of shares outstanding than it did 1 year ago.
  • CV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CV Yearly Shares OutstandingCV Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M
CV Yearly Total Debt VS Total AssetsCV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • An Altman-Z score of 17.74 indicates that CV is not in any danger for bankruptcy at the moment.
  • CV has a better Altman-Z score (17.74) than 95.14% of its industry peers.
  • There is no outstanding debt for CV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 17.74
ROIC/WACCN/A
WACC9.85%
CV Yearly LT Debt VS Equity VS FCFCV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 10M -10M -20M

2.3 Liquidity

  • A Current Ratio of 5.19 indicates that CV has no problem at all paying its short term obligations.
  • The Current ratio of CV (5.19) is better than 78.38% of its industry peers.
  • CV has a Quick Ratio of 4.50. This indicates that CV is financially healthy and has no problem in meeting its short term obligations.
  • CV has a Quick ratio of 4.50. This is in the better half of the industry: CV outperforms 79.46% of its industry peers.
Industry RankSector Rank
Current Ratio 5.19
Quick Ratio 4.5
CV Yearly Current Assets VS Current LiabilitesCV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.06%.
  • The Revenue has grown by 20.54% in the past year. This is a very strong growth!
EPS 1Y (TTM)-76.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)20.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • CV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.38% yearly.
  • Based on estimates for the next years, CV will show a very strong growth in Revenue. The Revenue will grow by 60.06% on average per year.
EPS Next Y-144.67%
EPS Next 2Y-8.41%
EPS Next 3Y14.38%
EPS Next 5YN/A
Revenue Next Year21.95%
Revenue Next 2Y29.78%
Revenue Next 3Y60.06%
Revenue Next 5YN/A

3.3 Evolution

CV Yearly Revenue VS EstimatesCV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 10M 20M 30M 40M
CV Yearly EPS VS EstimatesCV Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CV. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CV Price Earnings VS Forward Price EarningsCV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CV Per share dataCV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • CV's earnings are expected to grow with 14.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.41%
EPS Next 3Y14.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAPSOVISION INC

NASDAQ:CV (2/24/2026, 8:19:07 PM)

After market: 4.95 0 (0%)

4.95

-0.43 (-7.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners0.87%
Inst Owner Change40.01%
Ins Owners17.52%
Ins Owner Change1.53%
Market Cap231.86M
Revenue(TTM)21.39M
Net Income(TTM)-37.82M
Analysts84
Price Target10.71 (116.36%)
Short Float %1.29%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-857.46%
Min EPS beat(2)-1682.88%
Max EPS beat(2)-32.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.09%
Min Revenue beat(2)-6.75%
Max Revenue beat(2)0.58%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16%
EPS NY rev (1m)0%
EPS NY rev (3m)-25.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.84
P/FCF N/A
P/OCF N/A
P/B 11.34
P/tB 11.34
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.46
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -147.38%
ROE -185.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.21%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.19
Quick Ratio 4.5
Altman-Z 17.74
F-ScoreN/A
WACC9.85%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-144.67%
EPS Next 2Y-8.41%
EPS Next 3Y14.38%
EPS Next 5YN/A
Revenue 1Y (TTM)20.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year21.95%
Revenue Next 2Y29.78%
Revenue Next 3Y60.06%
Revenue Next 5YN/A
EBIT growth 1Y-75.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-34.46%
EBIT Next 3Y13.23%
EBIT Next 5YN/A
FCF growth 1Y-75.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.99%
OCF growth 3YN/A
OCF growth 5YN/A

CAPSOVISION INC / CV FAQ

What is the fundamental rating for CV stock?

ChartMill assigns a fundamental rating of 3 / 10 to CV.


Can you provide the valuation status for CAPSOVISION INC?

ChartMill assigns a valuation rating of 0 / 10 to CAPSOVISION INC (CV). This can be considered as Overvalued.


How profitable is CAPSOVISION INC (CV) stock?

CAPSOVISION INC (CV) has a profitability rating of 0 / 10.


What is the expected EPS growth for CAPSOVISION INC (CV) stock?

The Earnings per Share (EPS) of CAPSOVISION INC (CV) is expected to decline by -144.67% in the next year.